For example, anti–PD-1 antibodies increase the number CD4+ cells, which normalizes tumor blood flow, allowing more drug to reach the tumor tissues, and long-term use of enfortumab vedotin makes tumor tissue sensitive to CCs [23,24]. The gene discussed is CD4; the disease is neoplasm.